Sustainable Drug Discovery Can Advance Global Health
Discover how medicinal chemistry can advance sustainable drug discovery, tackle neglected diseases, improve access to medicines.
How Should Pharma Companies Audit AI Vendors?
“This is one of the riskiest industries there is because you're dealing with human lives, you're dealing with experimental protocols, and you're dealing with regulatory bodies where you might not get another shot at that clinical trial."
The EU Biotech Act Puts Medical AI Safeguards at a Crossroads
The EU Biotech Act aims to accelerate biotechnology development. Explore how proposed medical AI reforms could affect patient safety, compliance, and pharma competitiveness.
Can AI Diplomacy Build a Fairer Future for Global Health?
Explore how science diplomacy and ethical AI governance can shape a more equitable future for healthcare, pharmaceutical innovation, and global scientific collaboration.
Co-ordinated EU GMP Inspection Guidelines: What You Need to Know
New EU GMP inspection guidelines take effect in September 2026. Here is what you need to know about joint inspections, planning, and reporting.
Pharmaceutical Packaging for Patient Safety
Pharmaceutical packaging protects medicine quality and patient safety. We explore material risks, container closure systems, and emerging packaging technologies.